209 related articles for article (PubMed ID: 12111773)
21. [Immunoblastic lymphadenopathy (IBL)-like T cell lymphoma associated with granulocytopenia and autoimmune hemolytic anemia].
Osawa H; Otsuka T; Inoue T; Sumida I; Hanada M; Okamura T; Nakazato S
Rinsho Ketsueki; 1993 Feb; 34(2):165-70. PubMed ID: 7684093
[TBL] [Abstract][Full Text] [Related]
22. Hyperfractionated cyclophosphamide with high-doses of arabinosylcytosine and methotrexate (HyperCHiDAM Verona 897).
Todeschini G; Tecchio C; Pasini F; Benedetti F; Cantini M; Crippa C; Draisci M; Pizzolo G
Cancer; 2005 Aug; 104(3):555-60. PubMed ID: 15959910
[TBL] [Abstract][Full Text] [Related]
23. Bone marrow derived mesenchymal cell mobilization by granulocyte-colony stimulating factor after acute myocardial infarction: results from the Stem Cells in Myocardial Infarction (STEMMI) trial.
Ripa RS; Haack-Sørensen M; Wang Y; Jørgensen E; Mortensen S; Bindslev L; Friis T; Kastrup J
Circulation; 2007 Sep; 116(11 Suppl):I24-30. PubMed ID: 17846310
[TBL] [Abstract][Full Text] [Related]
24. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.
Sieber M; Bredenfeld H; Josting A; Reineke T; Rueffer U; Koch T; Naumann R; Boissevain F; Koch P; Worst P; Soekler M; Eich H; Müller-Hermelink HK; Franklin J; Paulus U; Wolf J; Engert A; Diehl V;
J Clin Oncol; 2003 May; 21(9):1734-9. PubMed ID: 12721249
[TBL] [Abstract][Full Text] [Related]
25. Phase I/II study of the rituximab-EPOCT regimen in combination with granulocyte colony-stimulating factor in patients with relapsed or refractory follicular lymphoma including evaluation of its cardiotoxicity using B-type natriuretic peptide and troponin T levels.
Niitsu N; Khori M; Hayama M; Kajiwara K; Higashihara M; Tamaru J
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):697-702. PubMed ID: 15701858
[TBL] [Abstract][Full Text] [Related]
26. Pilot study of modified version of CHOP plus radiotherapy for early-stage aggressive non-Hodgkin's lymphoma of the head and neck.
Nishioka T; Tsuchiya K; Nishioka S; Kitahara T; Ohmori K; Homma A; Aoyma H; Shindoh M; Shirato H
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):847-52. PubMed ID: 15465202
[TBL] [Abstract][Full Text] [Related]
27. High plasma D-dimer level is associated with decreased survival in patients with lung cancer.
Altiay G; Ciftci A; Demir M; Kocak Z; Sut N; Tabakoglu E; Hatipoglu ON; Caglar T
Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):494-8. PubMed ID: 17513096
[TBL] [Abstract][Full Text] [Related]
28. [Improvement of thrombocytopenia by administration of M-CSF in a patient with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia].
Endo A; Tajima F; Kawatani T; Kawasaki H
Rinsho Ketsueki; 1996 Sep; 37(9):863-6. PubMed ID: 8914477
[TBL] [Abstract][Full Text] [Related]
29. Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction: result of the double-blind, randomized, placebo-controlled stem cells in myocardial infarction (STEMMI) trial.
Ripa RS; Jørgensen E; Wang Y; Thune JJ; Nilsson JC; Søndergaard L; Johnsen HE; Køber L; Grande P; Kastrup J
Circulation; 2006 Apr; 113(16):1983-92. PubMed ID: 16531621
[TBL] [Abstract][Full Text] [Related]
30. Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Ringdén O; Labopin M; Gorin NC; Le Blanc K; Rocha V; Gluckman E; Reiffers J; Arcese W; Vossen JM; Jouet JP; Cordonnier C; Frassoni F
J Clin Oncol; 2004 Feb; 22(3):416-23. PubMed ID: 14691124
[TBL] [Abstract][Full Text] [Related]
31. [A case of RAEB-t treated by G-CSF showing complete remission after MST-16 treatment for subsequent reversible leukemia].
Murate T; Ohashi H; Kagami Y; Hotta T; Murase T; Hirota Y; Kimura K
Gan To Kagaku Ryoho; 1991 Sep; 18(12):2155-8. PubMed ID: 1716093
[TBL] [Abstract][Full Text] [Related]
32. [Lymphoma associated hemophagocytic syndrome with plasmacytosis in the bone marrow and hypergammaglobulinemia].
Ikewaki J; Ohtsuka E; Uno N; Ogata M; Kikuchi H; Nasu M; Yokoyama S
Rinsho Ketsueki; 1998 Dec; 39(12):1175-9. PubMed ID: 10028850
[TBL] [Abstract][Full Text] [Related]
33. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
Wong SF; Chan HO
Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
[TBL] [Abstract][Full Text] [Related]
34. [Microcellular lung carcinoma in patient with hepatosplenic T-cell lymphoma: a case report].
Kalac M; Ostojić S; Gasparov S; Planinc-Peraica A; Dominis M; Jaksić B
Lijec Vjesn; 2006; 128(3-4):76-8. PubMed ID: 16808095
[TBL] [Abstract][Full Text] [Related]
35. Human granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia: a Children's Cancer Group Study.
Heath JA; Steinherz PG; Altman A; Sather H; Jhanwar S; Halpern S; Pieters R; Shah N; Steinherz L; Tannous R; Terry W; Trigg ME;
J Clin Oncol; 2003 Apr; 21(8):1612-7. PubMed ID: 12697887
[TBL] [Abstract][Full Text] [Related]
36. [A risk of pulmonary edema associated with G-CSF pretreatment].
Kitamura S; Kinouchi K; Fukumitsu K; Takeuchi M; Matsuyama M; Miyamoto Y
Masui; 1997 Jul; 46(7):946-50. PubMed ID: 9251510
[TBL] [Abstract][Full Text] [Related]
37. [T-cell rich B-cell lymphoma associated with neutrophilia and thrombocytosis].
Kuroda H; Matsunaga T; Sakamaki S; Koike K; Terui T; Neda H; Ishitani K; Nobuoka A; Sato M; Kida M; Watanabe H; Yamaguchi J; Niitsu Y
Rinsho Ketsueki; 2007 Mar; 48(3):217-22. PubMed ID: 17441479
[TBL] [Abstract][Full Text] [Related]
38. [Collection of hematopoietic progenitor cells from healthy donors].
Bojanić I; Cepulić BG; Mazić S
Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
[TBL] [Abstract][Full Text] [Related]
39. [Granulocyte-colony stimulating factor-producing myeloma with clinical manifestations mimicking chronic neutrophilic leukemia].
Kusaba N; Yoshida H; Ohkubo F; Mishima K; Shimamastu K; Okamura T; Sata M
Rinsho Ketsueki; 2004 Mar; 45(3):228-32. PubMed ID: 15103937
[TBL] [Abstract][Full Text] [Related]
40. Effect of granulocyte colony-stimulating factor on IL-12 p40 production during chemotherapy for B-cell lineage non-Hodgkin's lymphoma patients.
Toubai T; Tanaka J; Ota S; Fukuhara T; Hashino S; Kondo T; Shono Y; Morioka M; Kawamura T; Masauzi N; Kakinoki Y; Kobayashi H; Kunieda Y; Kasai M; Kurosawa M; Asaka M; Imamura M
Eur J Haematol; 2006 Nov; 77(5):403-9. PubMed ID: 16930137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
